Herbst Ronald 4
4 · Pyxis Oncology, Inc. · Filed Oct 12, 2021
Insider Transaction Report
Form 4
Herbst Ronald
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to buy)
2021-10-07+28,252→ 28,252 totalExercise: $16.00Exp: 2031-10-07→ Common Stock (28,252 underlying)
Footnotes (1)
- [F1]These stock options vest 25% on the first anniversary of the October 7, 2021 grant date, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.